The following, which I obtained from http://thomas.loc.gov, is
excerpted from the Budget Resolution, which was recently passed in
the Senate, and from some recently introduced bills. Will this
determine future PD funding?  There are some discrepancies in the
time period over which funds get doubled. Note also that adding
2,000,000,000 to the President's 13,648,000,000 NIH budget for 1998
gives 14,960,000,000.

Phil Tompkins
Hoboken NJ
60/9

====================================================================
                           S.CON.RES.86

Resolved by the Senate (the House of Representatives concurring)
(Passed by the Senate)


SEC. 364. SENSE OF THE SENATE REGARDING THE NATIONAL INSTITUTES OF
HEALTH.

(a) FINDINGS- Congress finds that--

(1) heart disease was the leading cause of death for both men and
women in every year from 1970 to 1993;

(2) mortality rates for individuals suffering from prostate cancer,
skin cancer, and kidney cancer continue to rise;

(3) the mortality rate for African American women suffering from
diabetes is 134 percent higher than the mortality rate of Caucasian
women suffering from diabetes;

(4) asthma rates for children increased 58 percent from 1982 to
1992; (5) nearly half of all American women between the ages of 65
and 75 reported having arthritis;

(6) AIDS is the leading cause of death for Americans between the ages
of 24 and 44;

(7) the Institute of Medicine has described United States clinical
research to be 'in a state of crisis' and the National Academy of
Sciences concluded in 1994 that 'the present cohort of clinical
investigators is not adequate';

(8) biomedical research has been shown to be effective in saving
lives and reducing health care expenditures;

(9) research sponsored by the National Institutes of Health has
contributed significantly to the first overall reduction in cancer
death rates since recordkeeping was instituted;

(10) research sponsored by the National Institutes of health has
resulted in the identification of genetic mutations for osteoporosis;
Lou Gehrig's Disease, cystic fibrosis, and Huntington's Disease;
breast, skin and prostate cancer; and a variety of other illnesses;

(11) research sponsored by the National Institutes of Health has
been key to the development of Magnetic Resonance Imaging (MRI) and
Positron Emission Tomography (PET) scanning technologies;

(12) research sponsored by the National Institutes of Health has
developed effective treatments for Acute Lymphoblastic Leukemia
(ALL). Today, 80 percent of children diagnosed with Acute
Lymphoblastic Leukemia are alive and free of the disease after 5
years; and

(13) research sponsored by the National Institutes of Health
contributed to the development of a new, cost-saving cure for peptic
ulcers.

(b) SENSE OF THE SENATE- It is the sense of the Senate that the
function totals in this budget resolution assume that--

(1) appropriations for the National Institutes of Health should be
increased by 100 percent over the next 5 fiscal years;

(2) appropriations for the National Institutes of Health should be
increased by $2,000,000,000 in year 1999 over the amount appropriated
in fiscal year 1998;

(3) the budget resolution takes a major step toward meeting this
goal; and

(4) at a minimum, appropriations for the National Institutes of
Health should match the recommendations provided in the budget
resolution.

=====================================================================

Biomedical Revitalization Resolution of 1998
H.RES.363 IH   Feb 12, 1998

Expressing the sense of the House of Representatives that the
Federal investment in biomedical research should be increased by
$2,000,000,000 in fiscal year 1999.

Sponsors: GEKAS and PORTER

[My extract:]
                          RESOLUTION

Expressing the sense of the House of Representatives that the
Federal investment in biomedical research should be increased by
$2,000,000,000 in fiscal year 1999.

Whereas past investments in biomedical research have resulted in
better health, an improved quality of life for all Americans and a
reduction in national health care expenditures;

Whereas the Nation's commitment to biomedical research has expanded
the base of scientific knowledge about health and disease and
revolutionized the practice of medicine;

Whereas the Federal Government represents the single largest
contributor to biomedical research conducted in the United States;

Whereas biomedical research continues to play a vital role in the
growth of this Nation's biotechnology, medical device, and
pharmaceutical industries;

Whereas the origin of many of the new drugs and medical devices
currently in use is based in biomedical research supported by the
National Institutes of Health;

Whereas women have traditionally been underrepresented in medical
research protocols, yet are severely affected by diseases including
breast cancer, which will kill over 44,000 women this year; ovarian
cancer which will claim another 14,800 lives; and, osteoporosis and
cardiovascular disorders;

Whereas research sponsored by the National Institutes of Health is
responsible for the identification of genetic mutations relating to
nearly 100 diseases, including Alzheimer's disease, cystic fibrosis,
Huntington's disease, osteoporosis, many forms of cancer, and immune
deficiency disorders;

Whereas many Americans still face serious and life-threatening
health problems, both acute and chronic;

Whereas neurodegenerative diseases of the elderly, such as
Alzheimer's and Parkinson's disease threaten to destroy the lives of
millions of Americans, overwhelm the Nation's health care system, and
bankrupt the Medicare and Medicaid programs;

..........[snip]...................

Whereas the fundamental way science is conducted is changing at a
revolutionary pace, demanding a far greater investment in emerging new
technologies, research training programs, and in developing new skills
among scientific investigators;

Whereas this proposal is the first step toward doubling the National
Institutes of Health funding in five years;

Whereas funds necessary to meet this proposal may come from budget
surpluses, budget offsets, and the regular appropriations process;
Whereas the American economy's outstanding performance may result in
budget surpluses, which the American people support using to increase
biomedical research funded by the National Institutes of Health; and

Whereas polling data shows that Americans support a doubling of the
Federal investment in biomedical research: Now, therefore, be it

Resolved,

SECTION 1. SHORT TITLE.

This resolution may be cited as the `Biomedical Revitalization
Resolution of 1998'.

SEC. 2. SENSE OF THE HOUSE OF REPRESENTATIVES.

It is the sense of the House of Representatives that funding for the
National Institutes of Health should be increased by $2,000,000,000 in
fiscal year 1999 and that the budget resolution appropriately reflect
sufficient funds to achieve this objective.

=====================================================================

Biomedical Revitalization Resolution of 1998
S RES 170   Jan 29, 1998

Expressing the sense of the Senate that the Federal investment in
biomedical research should be increased by $2,000,000,000 in fiscal
year 1999.

Sponsors: SPECTER, HARKIN, FRIST, REED, SNOWE, DEWINE, and D'AMATO

[Senate version of H RES 363 above.]

=====================================================================

National Research Investment Act of 1998
S.1305 IS

To invest in the future of the United States by doubling the amount
authorized for basic scientific, medical, and pre-competitive
engineering research.

Sponsors: GRAMM, LIEBERMAN, DOMENICI, BINGAMAN

[My extract:]

(1) IN GENERAL- Subject to the limitations under paragraph (2),
there are authorized to be appropriated as funds for covered research
and development--

(A) for fiscal year 1999, $37,400,000,000, of which $14,960,000,000
shall be used by the National Institutes of Health of the Department
of Health and Human Services;

(B) for fiscal year 2000, $40,800,000,000, of which $16,320,000,000
shall be used by the National Institutes of Health of the Department
of Health and Human Services;

(C) for fiscal year 2001, $44,200,000,000, of which $17,680,000,000
shall be used by the National Institutes of Health of the Department
of Health and Human Services;

(D) for fiscal year 2002, $47,600,000,000, of which $19,040,000,000
shall be used by the National Institutes of Health of the Department
of Health and Human Services; (E) for fiscal year 2003,
$51,000,000,000, of which $20,400,000,000 shall be used by the
National Institutes of Health of the Department of Health and Human
Services;

(F) for fiscal year 2004, $54,400,000,000, of which $21,760,000,000
shall be used by the National Institutes of Health of the Department
of Health and Human Services;

(G) for fiscal year 2005, $57,800,000,000, of which $23,120,000,000
shall be used by the National Institutes of Health of the Department
of Health and Human Services;

(H) for fiscal year 2006, $61,200,000,000, of which $24,480,000,000
shall be used by the National Institutes of Health of the Department
of Health and Human Services;

(I) for fiscal year 2007, $64,600,000,000, of which $25,840,000,000
shall be used by the National Institutes of Health of the Department
of Health and Human Services; and

(J) for fiscal year 2008, $68,000,000,000, of which $27,200,000,000
shall be used by the National Institutes of Health of the Department
of Health and Human Services.

=====================================================================

National Research Investment Act of 1998
HR 3660 IH Apr 1, 1998

To invest in the future of the United States by doubling the amount
authorized for basic scientific, medical, and pre-competitive
engineering research.

KENNEDY, TAUSCHER, NEAL, FILNER, KUCINICH, MCGOVERN, ROMERO-BARCELO,
GEJDENSON, RIVERS, WOOLSEY, FROST, MCCARTHY, MORAN, SNYDER,
FALEOMAVAEGA, LATOURETTE, HOUGHTON, and DAVIS

[House version of Senate S 1305]